Libertatis Ergo Holding B.V.

Libertatis Ergo Holding B.V. (LEH) is an independent investment firm wholly owned by Leiden University, dedicated to supporting and investing in startup and spinout companies associated with the university's activities. LEH primarily focuses on life science and health sectors, aiming to bridge the gap between academic research and market application by providing financial support and educational programs to facilitate the commercialization of innovative technologies.

The firm's investment strategy emphasizes sustainable and ethical business practices, targeting companies that contribute positively to society and the environment. LEH operates as a lead seed investor, engaging in early-stage investments to foster the growth of high-impact technology ventures. Their portfolio includes a diverse range of sectors, such as biotechnology, medical devices, pharmaceuticals, and health technology, reflecting a commitment to advancing solutions that address significant societal challenges.

LEH's approach combines deep academic insight with entrepreneurial expertise, leveraging its strong presence on the Leiden Bio Science Park to drive innovation. By supporting companies like River BioMedics, which secured €2 million in funding to advance its cardiovascular disease pipeline, and dHealthIQ, which received €500,000 to validate its AI platform for elderly care and rehabilitation, LEH demonstrates its dedication to fostering impactful ventures that align with its mission of promoting societal and environmental well-being.